<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="22361">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02815735</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-68 (VISA-407)</org_study_id>
    <nct_id>NCT02815735</nct_id>
  </id_info>
  <brief_title>Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses</brief_title>
  <official_title>Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the subjective performance of the comfilcon A contact
      lens against lotrafilcon B contact lens after 4 weeks of reusable lens wear.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a 80 subject, randomized, bilateral, double-masked, dispensing, cross-over
      study comparing comfilcon A versus lotrafilcon B lenses over 4 weeks of daily wear for each
      lens pair.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>Up to 4 weeks</time_frame>
    <description>Comfort (insertion, end of the day, and overall) for comfilcon A and lotrafilcon B lenses assessed. Scale 0-10, 0=painful, 10=can't feel the lenses.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort during the day</measure>
    <time_frame>Up to 4 weeks</time_frame>
    <description>Comfort during the day for comfilcon A and lotrafilcon B lenses assessed via via SMS (short message service) text message. Scale 0-10, 0=painful, 10=can't feel the lenses.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>comfilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants wear comfilcon A lens for 4 weeks during the cross over study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lotrafilcon B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants wear lotrafilcon B lens for 4 weeks during the cross over study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>comfilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>comfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lotrafilcon B</intervention_name>
    <description>contact lens</description>
    <arm_group_label>lotrafilcon B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Spherical distance CL (Contact Lens) prescription between -1.00 and -6.00D (Diopter)
             OR in both eyes (inclusive)

          -  Adapted soft CL wearers (i.e. &gt;1 month) who are reusable lens wearers*

          -  Spectacle cylinder 0.75D in both eyes

          -  Correctable to 6/9 in both eyes

          -  Be between 18 and 34 years of age (inclusive)

          -  Able to read, comprehend and sign an informed consent

          -  Own a mobile phone and be able to respond to SMS survey during the period 8am - 8pm

          -  Willing to comply with the wear and study visit schedule

        Exclusion Criteria:

        Any of the following will render a subject ineligible for inclusion:

          -  Existing wearer of daily disposable contact lenses

          -  Known allergy to Opti-Free PureMoist multipurpose solution

          -  Any active corneal infection, injury or inflammation

          -  Systemic or ocular allergies, which might interfere with CL wear

          -  Systemic disease, which might interfere with CL wear

          -  Ocular disease, which might interfere with CL wear

          -  Strabismus or amblyopia

          -  Subjects who have undergone corneal refractive surgery

          -  Subjects with keratoconus or other severe corneal irregularity contraindicating lens
             wear

          -  Pregnant, planning a pregnancy or lactating

          -  Use of systemic/topical medication contraindicating CL wear

          -  Diabetic

          -  Site employees or family members of investigators

          -  Participation in any concurrent trial or in the last 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>34 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graeme Young</last_name>
    <role>Study Director</role>
    <affiliation>Visioncare Research Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eyesite</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG1 1EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brock and Houlford</name>
      <address>
        <city>Chew Magna</city>
        <state>Bristol</state>
        <zip>BS40 8PR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tempany's Boutique Opticians</name>
      <address>
        <city>Broadstone</city>
        <state>Dorset</state>
        <zip>BH18 8DP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chalmers Opticians</name>
      <address>
        <city>Cardiff</city>
        <state>Glamorgan</state>
        <zip>CF24 3RQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leightons</name>
      <address>
        <city>St Albans</city>
        <state>Hertfordshire</state>
        <zip>AL1 3LH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David Gould Opticians</name>
      <address>
        <city>Rawtenstall</city>
        <state>Lancashire</state>
        <zip>BB4 7QN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harrold Opticians</name>
      <address>
        <city>Uxbridge</city>
        <state>Middlesex</state>
        <zip>UB8 1JX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boots Opticians Ltd</name>
      <address>
        <city>Birmingham</city>
        <state>Warwickshire</state>
        <zip>B4 7TB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Visioncare Research Ltd.</name>
      <address>
        <city>Farnham</city>
        <zip>GU9 7EN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 1, 2017</lastchanged_date>
  <firstreceived_date>June 24, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
